| Literature DB >> 16458430 |
Li Jiao1, Manal M Hassan, Melissa L Bondy, James L Abbruzzese, Douglas B Evans, Donghui Li.
Abstract
We evaluated the association between the XPD exon 10 Asp(312)Asn and exon 23 Lys(751)Gln polymorphisms and the risk of pancreatic cancer in a hospital-based study of 344 patients and 386 controls frequency matched by age, gender, and race. Stratified analyses showed ever smokers carrying the Asn(312)Asn genotype had a significantly reduced risk when compared with those carrying the (312)Asp allele (OR=0.46, 95% confidence interval 0.24-0.88) (P for interaction=0.03). The (312)Asp-(751)Gln was identified as the putative at risk haplotype. Our study shows that the XPD gene polymorphism could be a genetic risk modifier for smoking-related pancreatic cancer.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16458430 PMCID: PMC1741855 DOI: 10.1016/j.canlet.2005.12.026
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679